ArticleiScience2026
Lymph node extracellular matrix skews the immune function of human fibroblastic reticular cells.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymph node (LN) fibroblastic reticular cells (FRCs) are key immunomodulators that regulate adaptive immune responses and provide structural support via extracellular matrix (ECM) production. However, how ECM composition shapes FRC-immune cell interactions remains unclear. Here, we show that ECM composition, specifically collagen type I, laminin α4, or laminin α5, critically determines the immunological status of human FRCs. Bulk RNA sequencing shows that FRCs grown on collagen closely resemble those in native human LN ECM, whereas laminin α4 and α5 differentially skew FRC transcriptomes toward homeostatic/tolerogenic or pro-inflammatory profiles, respectively. These ECM-imprinted FRC states subsequently shape distinct CD4
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.